These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1387313)

  • 1. Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2.
    Cabré F; Moreno JJ; Carabaza A; Ortega E; Mauleón D; Carganico G
    Biochem Pharmacol; 1992 Aug; 44(3):519-25. PubMed ID: 1387313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Antiflammins': two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2-inhibitory and anti-inflammatory activity.
    Märki F; Pfeilschifter J; Rink H; Wiesenberg I
    FEBS Lett; 1990 May; 264(2):171-5. PubMed ID: 2141575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins.
    Lloret S; Moreno JJ
    Biochem Pharmacol; 1992 Oct; 44(7):1437-41. PubMed ID: 1417964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
    Moreno JJ
    Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nonapeptide fragments of uteroglobin and lipocortin I on oedema and mast cell degranulation.
    Lloret S; Moreno JJ
    Eur J Pharmacol; 1994 Nov; 264(3):379-84. PubMed ID: 7535228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of vasocortin and nonapeptide fragments of uteroglobin and lipocortin I (antiflammins).
    Ialenti A; Doyle PM; Hardy GN; Simpkin DS; Di Rosa M
    Agents Actions; 1990 Jan; 29(1-2):48-9. PubMed ID: 2139299
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human type II phospholipase A2 lacks edema producing activity in rat.
    Morgan DW; Anderson CM; Meyers KP
    Eur J Pharmacol; 1993 Apr; 235(1):45-50. PubMed ID: 8519280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoids inhibit phospholipase A2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages.
    Hope WC; Patel BJ; Fiedler-Nagy C; Wittreich BH
    Inflammation; 1990 Oct; 14(5):543-59. PubMed ID: 2123476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides.
    Marastoni M; Scaranari V; Romualdi P; Donatini A; Ferri S; Tomatis R
    Arzneimittelforschung; 1993 Sep; 43(9):997-1000. PubMed ID: 8240467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
    Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
    Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Adv Exp Med Biol; 1990; 279():137-60. PubMed ID: 2151414
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of pancreatic phospholipase A2 activity by uteroglobin and antiflammin peptides: possible mechanism of action.
    Facchiano A; Cordella-Miele E; Miele L; Mukherjee AB
    Life Sci; 1991; 48(5):453-64. PubMed ID: 1992287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the anti-phospholipase A2 and anti-inflammatory activities of a synthetic nonapeptide from uteroglobin.
    Marastoni M; Salvadori S; Balboni G; Scaranari V; Santagada V; Romualdi P; Ferri S; Tomatis R
    Arzneimittelforschung; 1991 Mar; 41(3):240-3. PubMed ID: 1867659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Nature; 1988 Oct; 335(6192):726-30. PubMed ID: 2971881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
    Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
    Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiflammins on endotoxin-induced uveitis in rats.
    Chan CC; Ni M; Miele L; Cordella-Miele E; Ferrick M; Mukherjee AB; Nussenblatt RB
    Arch Ophthalmol; 1991 Feb; 109(2):278-81. PubMed ID: 1993038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action.
    Fawzy AA; Vishwanath BS; Franson RC
    Agents Actions; 1988 Dec; 25(3-4):394-400. PubMed ID: 3218613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line.
    Davidson FF; Lister MD; Dennis EA
    J Biol Chem; 1990 Apr; 265(10):5602-9. PubMed ID: 2138608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of synthetic peptides from annexin I and uteroglobin with lipid monolayers and their effect on phospholipase A2 activity.
    Newman RH; Freemont PS; Barton GJ; Crumpton MJ
    Biochem Soc Trans; 1990 Dec; 18(6):1233-4. PubMed ID: 2150950
    [No Abstract]   [Full Text] [Related]  

  • 20. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.
    Lindahl M; Tagesson C
    Inflammation; 1997 Jun; 21(3):347-56. PubMed ID: 9246576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.